(TheNewswire)
Calgary , Alberta – TheNewswire -- January 30 , 2024 – nDatalyze Corp. (“NDAT” or the“Corporation”) (CSE:NDAT) (OTC:NDATF) is pleased to announce the completion of its DNA-enhanced recordsgathering. This unique dataset combines YMI questionnaire answers withDNA data and is an important step in the integration of DNA data intothe YMI Clinical Decision Support System. Apreliminary DNA scoring formula has also been written. It isanticipated that the dataset and scoring formula will be forwarded toYork University pursuant to the Corporation’s previously-announcedClinical Study agreement with that Institution.
About YMI: YMIuses evidence-based, objective data from whole life experiences topredict individual mental states over time, and applies this knowledgetowards a fuller understanding of how mental health develops, and howto improve mental wellbeing. YMI combines supervised machine-learningwith a proprietary Reference Database to predict an individual’spredisposition toward a variety of common mental conditions, bothcurrent and forward in time.
YMI is poised to revolutionize mental health diagnoses while ensuringa sustainable revenue stream. By strategically addressing the causesof misdiagnosis, establishing credibility through clinical studies,and targeting key markets, YMI aligns both societal impact andfinancial success.
For Further Information, PleaseContact:
Dr. Keith Courtney, President (psychiatricaspects)
Email: drkeithcourtney@gmail.com
or
James Durward, CEO&CTO (technical aspects)
Email: jimd@ndatalyze.com
nDatalyze Website: https://www.ndatalyze.com
YMI Website: https://ymihealth.ca
Neither the Canadian Securities Exchange nor itsRegulation Services Provider (as that term is defined in the policiesof the Canadian Securities Exchange) accepts responsibility for theadequacy or accuracy of this release. This news release does notconstitute an offer to sell or a solicitation of an offer to sell anyof the securities in the United States. The securities have not beenand will not be registered under the United States Securities Act of1933, as amended (the "U.S. Securities Act") or any statesecurities laws and may not be offered or sold within the UnitedStates or to U.S. Persons unless registered under the U.S. SecuritiesAct and applicable state securities laws or an exemption from suchregistration is available. The information in this news releaseincludes certain information and statements about management's view offuture events, expectations, plans and prospects that constituteforward looking statements. These statements are based uponassumptions that are subject to significant risks and uncertainties.Because of these risks and uncertainties and as a result of a varietyof factors, the actual results, expectations, achievements orperformance may differ materially from those anticipated and indicatedby these forward-looking statements. Any number of factors could causeactual results to differ materially from these forward-lookingstatements as well as future results. Although the Corporationbelieves that the expectations reflected in forward looking statementsare reasonable, it can give no assurances that the expectations of anyforward-looking statements will prove to be correct. Except asrequired by law, the Corporation disclaims any intention and assumesno obligation to update or revise any forward-looking statements toreflect actual results, whether as a result of new information, futureevents, changes in assumptions, changes in factors affecting suchforward-looking statements or otherwise.
Copyright (c) 2024 TheNewswire - All rights reserved.